Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus
UMass Medical School’s research achievements in virology, immunology, host response, drug design and advanced therapeutics support an accelerated approach to crucial new research projects aimed at COVID-19 and the virus that causes it, SARS-CoV-2.
Investigators listed here are using expertise and insight developed while working on understanding and treating some of the world’s most challenging diseases. Successful research programs at UMass Medical School have developed vaccines or antiviral drugs for viruses such as HIV, Ebola, influenza and RSV; other UMMS labs are world leaders in the design and testing of new approaches to therapeutics, which they are now applying to SARS-CoV-2.
Current and upcoming clinical trials include:
Learn more about the researchers involved in clinical trials
For more information on clinical trials, visit the Conquering Diseases
website.
In their efforts to prevent new cases of COVID-19, researchers are:
Learn more about the researchers involved in diagnostics
and vaccine development
In their efforts toward developing treatments for COVID-19, researchers are working to:
In exploration of host response to SARS-CoV-2, researchers are:
UMass Medical School is conducting a community-facing survey in Worcester and six surrounding communities to assess how COVID-19 has affected ongoing day-to-day needs and help localities target relief efforts.
Read more